The combination therapy of imatinib and dasatinib achieves long-term molecular response in two imatinib-resistant and dasatinibintolerant patients with advanced chronic myeloid leukemia

For patients with chronic myeloid leukemia (CML) failing imatinib therapy, second-generation tyrosine kinase inhibitors (TKIs) are recommended. Here, we describe two patients with advanced CML who failed imatinib therapy and did not tolerate the recommended dose of dasatinib, but then achieved a maj...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Biomed Res
Hauptverfasser: Zhu, Yu, Pan, Liangqin, Hong, Ming, Liu, Weixing, Qiao, Chun, Li, Jianyong, Qian, Sixuan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Editorial Department of Journal of Biomedical Research 2016
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138586/
https://ncbi.nlm.nih.gov/pubmed/27924071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.30.20130172
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge